• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[结核病及其对抗结核药物的耐药性流行病学]

[The epidemiology of tuberculosis and of the resistance to antitubercular agents].

作者信息

Aït Khaled N, Enarson D, Billo N

机构信息

Union Internationale Contre la Tuberculose et les Maladies Respiratoires (UICTMR), Paris.

出版信息

Rev Mal Respir. 1997 Dec;14 Suppl 5:S8-18.

PMID:9496587
Abstract

Tuberculosis is once more a subject of world wide preoccupation; since 1985 a disturbing recrudescence of this disease has been noted in numerous countries related to population growth and the worsening of poverty in those countries without natural resources, and disadvantaged groups living on the margins of society in rich countries, along with the occurrence of an epidemic of HIV (VIH). In numerous developed countries where tuberculosis no longer represents a public health problem, the care services have little by little been closed or re-orientated and the principles of treatment of tuberculosis have been forgotten. The direct consequence of this has often been inadequate treatment and its corollary: the emergence of strains multiresistant to Isoniazid and Rifampicin. If the current epidemiological tendencies are confirmed and no supplementary action is taken, the WHO (OMS) has estimated that during the ten years between 1990 and the millennium there will be 88 million new cases of tuberculosis and 30 million people will die of tuberculosis. However the tendencies can be reversed and tuberculosis could still be eliminated. The struggle against tuberculosis is a world wide emergency and the hope of controlling the situation before an increase in multiresistant strains which would render the trend irreversible, rests on a general application of correct and coherent national programmes. Such a programme as the UICTMR model had already been carried out as has the proof of their efficacy.

摘要

结核病再次成为全球关注的问题;自1985年以来,在许多国家都注意到这种疾病令人不安地再度流行,这与人口增长以及那些没有自然资源的国家贫困状况的恶化有关,也与富裕国家处于社会边缘的弱势群体以及艾滋病毒(HIV)的流行有关。在许多结核病不再构成公共卫生问题的发达国家,医疗服务已逐渐关闭或重新调整方向,结核病治疗原则也被遗忘。其直接后果往往是治疗不充分及其必然结果:出现对异烟肼和利福平多重耐药的菌株。如果当前的流行病学趋势得到证实且不采取额外行动,世界卫生组织(WHO)估计,在1990年至千禧年的十年间,将有8800万新的结核病病例,3000万人将死于结核病。然而,这些趋势是可以扭转的,结核病仍有可能被消除。抗击结核病是全球的紧急任务,要在多重耐药菌株增加到使趋势不可逆转之前控制住局面,希望寄托在正确且连贯的国家方案的普遍实施上。像UICTMR模式这样的方案已经实施,并且其有效性也已得到证明。

相似文献

1
[The epidemiology of tuberculosis and of the resistance to antitubercular agents].[结核病及其对抗结核药物的耐药性流行病学]
Rev Mal Respir. 1997 Dec;14 Suppl 5:S8-18.
2
[Drug-resistant pulmonary tuberculosis at the penitentiaries].[监狱中的耐多药肺结核]
Probl Tuberk Bolezn Legk. 2008(12):60-3.
3
[Multiresistant tuberculosis in New York].
Schweiz Rundsch Med Prax. 1993 Oct 5;82(40):1105-7.
4
Tuberculosis control and research strategies for the 1990s: memorandum from a WHO meeting.20世纪90年代结核病控制与研究策略:世界卫生组织会议备忘录
Bull World Health Organ. 1992;70(1):17-21.
5
Tuberculosis: a survey and review of current literature.结核病:当前文献综述与调查
Curr Opin Pulm Med. 1995 May;1(3):234-42.
6
Multidrug-resistant tuberculosis (MDR-TB): epidemiology, prevention and treatment.耐多药结核病:流行病学、预防与治疗
Br Med Bull. 2005 Jun 14;73-74:17-24. doi: 10.1093/bmb/ldh047. Print 2005.
7
[Situation of tuberculosis in the world and the role expected of Japan in the global fight against tuberculosis].
Kekkaku. 1989 Nov;64(11):721-30.
8
Anti-tuberculosis drug resistance and HIV co-infection in Phnom Penh, Cambodia.柬埔寨金边的耐多药结核病与艾滋病毒合并感染情况
Southeast Asian J Trop Med Public Health. 2009 Jan;40(1):104-7.
9
Study of drug resistance in previously treated tuberculosis patients in Gujarat, India.印度古吉拉特邦既往治疗过的结核病患者的耐药性研究。
Int J Tuberc Lung Dis. 2002 Dec;6(12):1098-101.
10
Global aspects of tuberculosis in children.儿童结核病的全球概况。
Paediatr Respir Rev. 2001 Jun;2(2):91-6. doi: 10.1053/prrv.2000.0115.